These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3794746)

  • 21. Adenylate cyclase and ATPase activities in red cell membranes of patients and genetic carriers of Duchenne muscular dystrophy.
    Wacholtz MC; Raible DG; Jackowski S; Rodan SB; Rodan GA; Sha'afi RI
    Clin Chim Acta; 1979 Sep; 96(3):255-9. PubMed ID: 158446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Discriminant analysis of methods for detecting the heterozygote carrier state for the Duchenne muscular dystrophy gene].
    Khrennikov VIu; Sitnikov VF; Deev AI; Svintsitskiĭ IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):14-8. PubMed ID: 3223151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescent probe analysis of erythrocyte membranes in myotonic dystrophy.
    Chalikian DM; Barchi RL
    Neurology; 1980 Mar; 30(3):277-85. PubMed ID: 7189027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular organization of erythrocyte membranes in Duchenne muscular dystrophy].
    Falcioni AM; Ferretti G; Mazzanti L; Curatola G
    Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2307-12. PubMed ID: 6279127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration in erythrocyte membrane structure in Duchenne muscular dystrophy.
    Wakayama Y; Hodson A; Pleasure D; Bonilla E; Schotland DL
    Ann Neurol; 1978 Sep; 4(3):253-6. PubMed ID: 718137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy.
    Sato B; Nishikida K; Samuels LT; Tyler FH
    J Clin Invest; 1978 Feb; 61(2):251-9. PubMed ID: 23391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Red blood cell alterations in muscular dystrophy: the role of lipids.
    Plishker GA; Appel SH
    Muscle Nerve; 1980; 3(1):70-81. PubMed ID: 6246420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of water permeability and proteins of erythrocyte membranes in patients with Duchenne muscular dystrophy.
    Benga G; Popescu O; Pop VI; Ionescu I; Muresan A; Borza V; Hodârnău A; Popescu M; Serbu AM; Benga I
    Muscle Nerve; 1989 Apr; 12(4):294-301. PubMed ID: 2770782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrin extractability from erythrocytes in Duchenne muscular dystrophy patients and carriers and in other myopathies.
    Gargioni G; Chiaffoni G; Bonadonna G; Corradini P; Lechi C; de Grandis D; Zatti M
    Clin Chim Acta; 1985 Feb; 145(3):259-65. PubMed ID: 3987029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osmotic fragility of erythrocytes in Duchenne muscular dystrophy.
    Lloyd SJ; Nunn MG
    Br Med J; 1978 Jul; 2(6132):252. PubMed ID: 678893
    [No Abstract]   [Full Text] [Related]  

  • 31. Apparent alterations of erythrocyte acetylcholinesterase and other membrane proteins in Duchenne muscular dystrophy: a further example of a generalized membrane defect associated with hereditary muscular dystrophy.
    Das PK; Graesslin D; Goedde HW
    Biochem Soc Trans; 1976; 4(4):723-4. PubMed ID: 1001749
    [No Abstract]   [Full Text] [Related]  

  • 32. Palmitoleic acid in erythrocytes from carriers of Duchenne muscular dystrophy.
    Rao GA; Siler K; Larkin EC
    Science; 1978 Jun; 200(4348):1416. PubMed ID: 663625
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical compositional studies of erythrocyte membranes in Duchenne muscular dystrophy.
    Godin DV; Bridges MA; MacLeod PJ
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):331-49. PubMed ID: 674819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of membrane phosphorylation in erythrocyte membranes from patients with Duchenne muscular dystrophy.
    Vickers JD; McComas AJ; Rathbone MP
    Can J Neurol Sci; 1978 Nov; 5(4):437-42. PubMed ID: 743652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphology and deformability of erythrocytes in muscular dystrophy].
    Garceau C; Leblond PF; Lyonnais J; Beaupré A
    Nouv Rev Fr Hematol (1978); 1978; 20(4):585-98. PubMed ID: 377225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A study of sialic acid of erythrocyte membranes in Duchenne muscular dystrophy].
    Shen DG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Dec; 21(6):349-51, 385. PubMed ID: 3248452
    [No Abstract]   [Full Text] [Related]  

  • 37. Methylation of erythrocyte membrane phospholipids in patients with myotonic and Duchenne muscular dystrophy.
    Moore RB; Appel SH
    Exp Neurol; 1980 Nov; 70(2):380-91. PubMed ID: 7428902
    [No Abstract]   [Full Text] [Related]  

  • 38. Allosteric transition of erythrocyte alkaline phosphatase from Duchenne muscular dystrophy (DMD) patients and Duchenne muscular dystrophy carriers (Homo sapiens).
    Goldemberg AL; García AM; Fernández H; Fortunato M; Sánchez JJ; Trucco RE
    Int J Biochem; 1988; 20(7):703-6. PubMed ID: 2846381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte deformation in human muscular dystrophy.
    Matheson DW; Howland JL
    Science; 1974 Apr; 184(4133):165-6. PubMed ID: 4815722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.